19 May 2013
Keywords: sanofi, expands, access, immunogen, tap, technology, firm
Article | 18 August 2008
US firm ImmunoGen says that French drug major Sanofi-Aventis has exercised its option under a 2006 agreement for expanded access to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 August 2008
17 May 2013
© 2013 thepharmaletter.com